Recently Michael Causey, Editor-in-Chief ACRP, led an episode of ACRPtv addressing the topic of patient recruitment and clinical research as a care option. TrialSite considers guest, Jennifer Byrne, CEO of Javara, a thought leader in the nascent clinical research as a care option space. Ms. Byrne reviewed the growing importance providers place on research while articulating that the days of thinking of a clinical trial and associated “subject” or “participant” as an individual in a scientific silo or bubble are rapidly giving way to a new reality where clinical trial professionals understand a study as but one touch point in a continuum of health care interactions for that whole person.
ACRP TV interviewed Javara CEO Jennifer Byrne, an experienced clinical trials execution professional Ms. Byrne reports that in the days of COVID-19 providers (individuals doctors to those managing hospitals or even health systems) become incredibly supportive of research endeavors. The openness and willingness to embrace research augmentation for activities such as patient recruitment is palpable as since the pandemic raged, research takes on an ever more paramount role in identifying treatment pathways for those infected with SARS-CoV-2.
Clinical Research as a Care is a mindset, a paradigm shift that Ms. Byrne assures will only grow in prevalence and prominence. Afterall can we really think of a patient in a scientific silo as truly representative of that person, their health care and wellbeing, and for that matter, when looking at collections of patients the greater population? No we cannot. A mindset shift certainly takes hold to consider an individual in the context of their (and population’s) continuum of care and that although a clinical trial may have a particular objective, that “subject” is a real-world person with real world, health continuum needs and challenges. This is an opportunity to actually transform the term “patient centricity” into something of worth: with meaning and purpose. This shift in paradigm or mindset impacts how a clinical research team will think about the patient and their experience, before, during and after the clinical trial suggests Byrne.
Call to Action: Follow the link to ACRPtv and catch this brief interview. Its brief and high level but can prompt many involved with clinical trials to begin thinking more about research as care, the implications, obligations and responsibilities and even some of the liabilities. Interested in entering the professional field of clinical research. Consider joining one of the industry’s most important member organizations: Association of Clinical Research Professionals (ACRP).